Shahd Alfudail
Riyadh,Saudi Arabia
Summary
PharmD-qualified pharmacist with extensive clinical training across major tertiary care hospitals in Saudi Arabia. Experienced in academic research, regulatory affairs, and pharmaceutical industry training. Currently completing an Executive Master's in Drug Regulatory Affairs, with strong interest in pharmacovigilance, drug safety, and regulatory science. Skilled in drug information, medication safety, clinical research support, and healthcare quality improvement.
Overview
1
1
year of professional experience
1
1
Certification
Work history
Academic Researcher
ITKAN Consulting Group
, Saudi Arabia
2022.11 - 2023.12
- Contributed to national registry projects including Multiple Sclerosis registry
- Coordinated with physicians and healthcare professionals across multiple hospitals
- Supported data collection, validation, and reporting
- Delivered workshops and training sessions for healthcare users
Education
Doctor of Pharmacy (PharmD) -
Princess Nourah bint Abdulrahman University
Riyadh, Saudi Arabia 4 2012 - 1 2019
Executive Master - Drug Regulatory Affairs
King Saud University
Saudi ArabiaSkills
- Pharmacovigilance
- Regulatory Affairs
- Drug Information
- Medication Safety
- Clinical Research
- Medical Communication
- Quality Improvement
- Data Collection & Analysis
- Scientific Presentation
Certification
- Pharmacovigilance and Drug Safety certificate (2025)
- Antibiotic Stewardship (2025)
- Drug Use, Drug Policy and Health (2025)
- Case Studies in Personalised Medicine (2024)
- Responsible Medication Prescribing for Older Adults (2024)
- Clinical Implications of Project Management in Healthcare (2023)
- Basic ECG (2022)
- Good Clinical Practice (NIDA Clinical Trials Network)
- BLS Provider
References
Available upon request
Publications & Research
- Does nephrotoxicity develop less frequently when vancomycin is combined with imipenem-cilastatin than with meropenem? (2019)
- Poster Presentation – ECCMID 2019, Netherlands
- Assessing the Incidence, Frequency and Pattern of Bleeding with Rivaroxaban Among Patients at Tertiary Care Hospital
- Poster Presentations – DUPHAT 2018, SIPHA 2018
Clinical Training & Rotations
- Prince Sultan Cardiac Center – Drug Information
- King Abdullah University Hospital – Medication Safety & Drug Information
- Prince Sultan Military Medical City – TPN, Quality, Outpatient & Inpatient Pharmacy
- Security Forces Hospital – Oncology
- King Faisal Specialist Hospital & Research Center – Research
- King Khaled Eye Specialist Hospital – Inpatient Pharmacy
Industry & Regulatory Experience
- Regulatory Affairs Associate – Bio-Standards
- Pharmaceutical Industry Training Program – Roche
- Product Specialist – Boehringer Ingelheim, Riyadh
- Research & Studies – Saudi Food and Drug Authority (SFDA)
- Nanotechnology Research Training – KACST
currentations & Volunteering
- Saudi National Registry for Multiple Sclerosis Workshop
- Virtual Pharmacy Presentation
- The Pharmacist's Role in Quality Improvement
- Prince Sultan Cardiac Center Heart Health Campaign
- Public Awareness Day for Hemophilia & Bleeding Disorders
Timeline
Academic Researcher
ITKAN Consulting Group
2022.11 - 2023.12
Doctor of Pharmacy (PharmD) -
Princess Nourah bint Abdulrahman University
4 2012 - 1 2019
Executive Master - Drug Regulatory Affairs
King Saud University